Evidence mapPaperPMID 36725436Full record

ArticleVaccine2023

Impact of COVID-19 vaccination in post-COVID cardiac complications.

Josefina B Parodi, Agustín Indavere, Pamela Bobadilla Jacob, Guillermo C Toledo, Rubén G Micali, Gabriel Waisman, Walter Masson, Eduardo D Epstein, Melina S Huerin

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Pathogenic mechanisms of cardiovascular damage in COVID-19.Molecular medicine (Cambridge, Mass.) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Josefina B ParodiInstituto Cardiovascular Lezica, Buenos Aires, Argentina. Electronic address: josefinab.parodi@gmail.com.
Agustín IndavereInstituto Cardiovascular Lezica, Buenos Aires, Argentina.
Pamela Bobadilla JacobInstituto Cardiovascular Lezica, Buenos Aires, Argentina.
Guillermo C ToledoInstituto Cardiovascular Lezica, Buenos Aires, Argentina.
Rubén G MicaliInstituto Cardiovascular Lezica, Buenos Aires, Argentina.
Gabriel WaismanInstituto Cardiovascular Lezica, Buenos Aires, Argentina.
Walter MassonHospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Eduardo D EpsteinInstituto Cardiovascular Lezica, Buenos Aires, Argentina.
Melina S HuerinInstituto Cardiovascular Lezica, Buenos Aires, Argentina.
Instituto Cardiovascular de Buenos Aires · ARHospital Italiano de Buenos Aires · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAfter the acute infection, COVID-19 can produce cardiac complications as well as long-COVID persistent symptoms. Although vaccination against COVID-19 represented a clear reduction in both mortality and ICU admissions, there is very little information on whether this was accompanied by a decrease in the prevalence of post-COVID cardiac complications. The aim of this study was to analyze the relationship between COVID-19 vaccination and the prevalence of post-COVID cardiac injury assessed by echocardiogram, and long-COVID persistent cardiac symptoms.

methodsAll patients who consulted for post-COVID evaluation 14 days after discharge from acute illness were included. Patients with heart disease were excluded. The relationship between complete vaccination scheme (at least two doses applied with 14 days or more since the last dose) and pathological echocardiographic findings, as well as the relationship of vaccination with persistent long-COVID symptoms, were evaluated by multivariate analysis, adjusting for age, sex and clinical variables that would have shown significant differences in univariate analysis.

resultsFrom 1883 patients, 1070 patients (56.8%) suffered acute COVID-19 without a complete vaccination scheme. Vaccination was associated with lower prevalence of cardiac injury (1.35% versus 4.11%, adjusted OR 0.33; 95% CI 0.17-0.65, p=0.01). In addition, vaccinated group had a lower prevalence of persistent long-COVID symptoms compared to unvaccinated patients (10.7% versus 18.3%, adjusted OR 0.52; 95% CI 0.40-0.69, p<0.001).

conclusionVaccination against COVID-19 was associated with lower post-COVID cardiac complications and symptoms, reinforcing the importance of fully vaccinating the population.

Indexed as

COVID-19COVID-19 VaccinesHeart DiseasesHumansPost-Acute COVID-19 SyndromeVaccinationCOVID-19 VaccinesCardiomyopathyCOVID-19EchocardiographyMyocarditisPost-acute COVID-19 syndromeSARS-CoV-2Vaccination

Identifiers

PMID36725436
PMCPMC9885297
OpenAlexW4318203511

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.